Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Melinta: A Pure-Play Antibiotics Specialist Rises

Jan 23 2018

• By Jessica Merrill

GoldKeyInPuzzle_1200x675

Related Content

Melinta Expands Portfolio, TMC Narrows Focus To LDL Reduction With Anti-Infective Deal

Nov 29 2017

Melinta To Launch First Commercial Drug Baxdela Independently

Jun 22 2017

Merger With Cempra Takes Melinta Public, Will Help Launch Baxdela

Aug 09 2017

US Approval Of Vabomere Could Help Alleviate TMC's Financial Troubles

Aug 31 2017

Related Companies

Melinta Therapeutics, Inc.

Cubist Pharmaceuticals, Inc.

Merck & Co., Inc.

Melinta Therapeutics, Inc.

The Medicines Company

Pfizer Inc.

Pfizer Inc.

Bausch Health Companies Inc.

Bausch Health Companies Inc.

Allergan plc

Additional Topics

Business Strategies Launches Companies Advertising, Marketing & Sales Pricing Strategies Commercial Infectious Diseases BioPharmaceutical

More from Strategy

More from Business

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.